Danaher (DHR) Net Income towards Common Stockholders (2009 - 2026)
Danaher (DHR) posted quarterly Net Income towards Common Stockholders of $1.0 billion for Q1 2026, up 7.86% year-over-year from $954.0 million in Q1 2025, and down 13.02% on a QoQ basis from $1.2 billion in Q4 2025.
Danaher (DHR) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Danaher (DHR) has reported Net Income towards Common Stockholders for 18 consecutive years, with $1.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 7.86% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $3.7 billion (down 2.39% YoY), while the FY2025 annual figure was $3.6 billion, down 7.31% from the prior year.
- Net Income towards Common Stockholders came in at $1.0 billion for Q1 2026 at Danaher, down from $1.2 billion in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $2.2 billion in Q4 2022, with the low at $555.0 million in Q2 2025.
- Average Net Income towards Common Stockholders over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2024.
- Across the five-year window, Net Income towards Common Stockholders surged 38.85% in 2022 and plunged 51.18% in 2023, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at $2.2 billion in 2022, then slumped by 51.18% to $1.1 billion in 2023, then grew by 0.65% to $1.1 billion in 2024, then grew by 8.93% to $1.2 billion in 2025, then slipped by 13.02% to $1.0 billion in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $1.0 billion, $1.2 billion, and $908.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 141.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | -40.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 27, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.18 Bn |
| Sep 26, 2025 | 908.00 Mn |
| Jun 27, 2025 | 555.00 Mn |
| Mar 28, 2025 | 954.00 Mn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 27, 2024 | 818.00 Mn |
| Jun 28, 2024 | 907.00 Mn |
| Mar 29, 2024 | 1.09 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Sep 29, 2023 | 1.13 Bn |
| Jun 30, 2023 | 1.11 Bn |
| Mar 31, 2023 | 1.43 Bn |
| Dec 31, 2022 | 2.21 Bn |
| Sep 30, 2022 | 1.55 Bn |
| Jul 1, 2022 | 1.66 Bn |
| Apr 1, 2022 | 1.68 Bn |
| Dec 31, 2021 | 1.75 Bn |
| Oct 1, 2021 | 1.12 Bn |
| Jul 2, 2021 | 1.74 Bn |